Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites

British Journal of Pharmacology

Volumn 143, Issue 6, 2004, Pages 666-684

  Alewijnse, Astrid E ^a   Peters, Stephan L M ^a   Michel, Martin C ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Angiogenesis; Ceramide; Heart; Sphingosine; Sphingosine 1 phosphate; Sphingosylphosphorylcholine; Vasoconstriction

Indexed keywords

CALCIUM CHANNEL L TYPE; CERAMIDE; G PROTEIN COUPLED RECEPTOR; ION CHANNEL; RECEPTOR SUBTYPE; RYANODINE RECEPTOR; SPHINGOMYELIN; SPHINGOSINE 1 PHOSPHATE; SPHINGOSYLPHOSPHORYLCHOLINE; TUMOR NECROSIS FACTOR; VASCULOTROPIN;

ANGIOGENESIS; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL MEMBRANE; CELL METABOLISM; CELL MIGRATION; CELL PROLIFERATION; ENDOTHELIUM CELL; HEART DISEASE; HOMEOSTASIS; HUMAN; INOTROPISM; MOLECULAR CLONING; NONHUMAN; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION; VASOCONSTRICTION; VASODILATATION;

ANIMALS; CARDIOVASCULAR AGENTS; CARDIOVASCULAR SYSTEM; HUMANS; LYSOPHOSPHOLIPIDS; RECEPTORS, LYSOSPHINGOLIPID; SPHINGOMYELINS; SPHINGOSINE;

EID: 8844254137     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705934     Document Type: Review

References (146)

1. ALLENDE, M.L. & PROIA, R.L. (2002). Sphingosine-1-phosphate receptors and the development of the vascular system. Biochem. Biophys. Acta, 1582, 222-227.
2. ALLENDE, M.L., YAMASHITA, T. & PROIA, R.L. (2003). G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation. Blood, 102, 3665-3667.
3. ALTMANN, C. FETSCHER, C., BÖYÜKBAS, D. & MICHEL, M.C. (2003a). Contraction of mesenteric resistance vessels by sphingosine-1-phosphate and sphingosylphosphorylcholine in aged rats. Naunyn-Schmiedeberg's Arch. Pharmacol., 367 (Suppl), R57.
4. ALTMANN, C., FETSCHER, C., BÖYÜKBAS, D. & MICHEL, M.C. (2003b). Effects of sphingosine-1-phosphate, sphingosylphosphorylcholine and ceramide on mesenteric artery contraction and relaxation in spontaneously hypertensive rats. Br. J. Pharmacol., 138 (Suppl), 157.
5. ALTMANN, C., FETSCHER, C., BÖYÜKBAS, D. & MICHEL, M.C. (2003c). Rat microvessel relaxation by ceramide, isoprenaline and nitroprusside sodium: differential regulation in genetic hypertension and aging. FASEB J., 17, 397.3.
6. ALTMANN, C., STEENPAß, V., CZYBORRA, P., HEIN, P. & MICHEL, M.C. (2003d). Comparison of signalling mechanisms involved in rat mesenteric microvessel contraction by noradrenaline and sphingosylphosphorylcholine. Br. J. Pharmacol., 138, 261-271.
7. 2+ transients and contraction of adult rat cardiomyocytes. Am. J. Physiol., 282, C1339-C1347.
8. ANCELLIN, N. & HLA, T. (1999). Differential pharmacological properties and signal transduction of the sphingosine 1-phosphate receptors EDG-1, EDG-3, and EDG-5. J. Biol. Chem., 274, 18997-19002.
9. BAI, J., HEEMANN, U. & MICHEL, M.C. (2002). Comparison of renal effects of systemic and intrarenal administration of sphingosylphosphorylcholine. Br. J. Pharmacol., 135 (Suppl), 245.
10. BAYLESS, K.J. & DAVIS, G.E. (2003). Sphingosine-1-phosphate markedly induces matrix metalloproteinase and integrin-dependent human endothelial cell invasion and lumen formation in three-dimensional collagen and fibrin matrices. Biochem. Biophys. Res. Commun., 312, 903-913.
11. 4 suppresses ERK activation in a ligand-independent manner. Biochemistry, 42, 12181-12191.
12. BENEDIKTSDOTTIR, V.E., JONSDOTTIR, A.M., SKULADOTTIR, B.H., GRUNBERG, A., SKARPHEDINSSON, J.O., HELGASON, J. & GUDBJARNASON, S. (2002). Sphingosine modulation of cAMP levels and beating rate in rat heart. Fundam. Clin. Pharmacol., 16, 495-502.
13. BETTO, R., TERESI, A., TURCATO, F., SALVIATI, G., SABBADINI, R.A., KROWN, K., GLEMBOTSKI, C.C., KINDMAN, L.A., PEREON, Y., YASUI, K. & PALADE, P.T. (1997). Sphingosylphosphorylcholine modulates the ryanodine receptor/calcium- release channel of cardiac sarcoplasmic reticulum membranes. Biochem. J., 322, 327-333.
14. BIELAWSKA, A.E., SHAPIRO, J.P., JIANG, L., MELKONYAN, H.S., PIOT, C., WOLFE, C.L., TOMEI, L.D., HANNUN, Y.A. & UMANSKY, S.R. (1997). Ceramide is involved in triggering of cardiomyocyte apoptosis induced by ischaemia and reperfusion. Am. J. Pathol., 151, 1257-1263.
15. BISCHOFF, A., CZYBORRA, P., FETSCHER, C., MEYER ZU HERINGDORF, D., JAKOBS, K.H. & MICHEL, M.C. (2000a). Sphingosine-I-phosphate and sphingosylphosphorylcholine constrict renal and mesenteric microvessels in vitro. Br. J. Pharmacol., 130, 1871-1877.
16. BISCHOFF, A., CZYBORRA, P., MEYER ZU HERINGDORF, D., JAKOBS, K.H. & MICHEL, M.C. (2000b). Sphingosine-1-phosphate reduces rat renal and mesenteric blood flow in vivo in a pertussis toxin-sensitive manner. Br. J. Pharmacol., 130, 1878-1883.
17. BISCHOFF, A., FINGER, J. & MICHEL, M.C. (2001a). Nifedipine inhibits sphingosine-1-phosphate-induced renovascular contraction in vitro and in vivo. Naunyn-Schmiedeberg's Arch. Pharmacol., 364, 179-182.
18. BISCHOFF, A., MEYER ZU HERINGDORF, D., JAKOBS, K.H. & MICHEL, M.C. (2001b). Lysosphingolipid receptor-mediated diuresis and natriuresis in anaesthetised rats. Br. J. Pharmacol., 132, 1925-1933.
19. BOGUSLAWSKI, G., GROGG, J.R., WELCH, Z., CIECHANOWICZ, S., SLIVA, D., KOVALA, A.T., MCGLYNN, P., BRINDLEY, D.N., RHOADES, R.A. & ENGLISH, D. (2002). Migration of vascular smooth muscle cells induced by sphingosine 1-phosphate and related lipids: potential role in the angiogenic response. Exp. Cell Res., 274, 264-274.
20. BOGUSLAWSKI, G., LYONS, D., HARVEY, K.A., KOVALA, A.T. & ENGLISH, D. (2000). Sphingosylphosphorylcholine induces endothelial cell migration and morphogenesis. Biochem. Biophys. Res. Commun., 272, 603-609.
21. BOLZ, S.S., VOGEL, L., SOLLINGER, D., DERWAND, R., BOER, C., PITSON, S.M., SPIEGEL, S. & POHL, U. (2003a). Sphingosine kinase modulates microvascular tone and myogenic responses through activation of RhoA/Rho kinase. Circulation, 108, 342-347.
22. BOLZ, S.S., VOGEL, L., SOLLINGER, D., DERWAND, R., DE WIT, C., LOIRAND, G. & POHL, U. (2003b). Nitric oxide-induced decrease in calcium sensitivity of resistance arteries is attributable to activation of the myosin light chain phosphatase and antagonized by the RhoA/Rho kinase pathway. Circulation, 107, 3081-3087.
23. + current in guinea-pig atrial myocytes by sphingosine-1-phosphate. J. Physiol. (London), 489, 701-707.
24. BÜNEMANN, M., LILIOM, K., BRANDTS, B.K., POTT, L., TSENG, J.-L., DESIDERIO, D.M., SUN, G., MILLER, D. & TIGYI, G. (1996). A novel membrane receptor with high affinity for lysosphingomyelin and sphingosine 1-phosphate in atrial myocytes. EMBO J., 15, 5527-5534.
25. CARMELIET, P. (2003). Angiogenesis in health and disease. Nat. Med., 9, 653-660.
26. CAVALLI, A.L., LIGUTTI, J.A., GELLINGS, N.M., CASTRO, E., PAGE, M.T., KLEPPER, R.E., PALADE, P.T., MCNUTT, W.T. & SABBADINI, R.A. (2002). The role of TNFα and sphingolipid signaling in cardiac hypoxia: evidence that cardiomyocytes release TNFα and sphingosine. Basic Appl. Myol., 12, 167-175.
27. 2+-dependent pathway. Am. J. Physiol., 275, C1255-C1263.
28. 2+ signalling mechanisms induced by ATP and sphingosylphosphorylcholine in porcine aortic smooth muscle cells. Br. J. Pharmacol., 129, 1365-1374.
29. CHUN, J., GOETZL, E.J., HLA, T., IGARASHI, Y., LYNCH, K.R., MOOLENAAR, W., PYNE, S. & TIGYI, G. (2002). International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature. Pharmacol. Rev., 54, 265-269.
30. CLAIR, T., AOKI, J., KOH, E., BANDLE, R.W., NAM, S.W., PTASZYNSKA, M.M., MILLS, G.B., SCHIFFMANN, E., LIOTTA, L.A. & STRACKE, M.L. (2003). Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate. Cancer Res., 63, 5446-5453.
31. 2+ release in vascular myocytes. J. Biol. Chem., 275, 9596-9603.
32. + channels. Biochem. Pharmacol., 66, 1861-1870.
33. COUSSIN, F., SCOTT, R.H., WISE, A. & NIXON, G.F. (2002). Comparison of sphingosine 1-phosphate-induced intracellular signaling pathways in vascular smooth muscles: differential role in vasoconstriction. Circ. Res., 91, 151-157.
34. COWLEY JR, A.W. (1992). Long-term control of aterial blood pressure. Physiol. Rev., 12, 231-300.
35. CZYBORRA, P., SAXE, M., FETSCHER, C., MEYER ZU HERINGDORF, D., HERZIG, S., JAKOBS, K.H., MICHEL, M.C. & BISCHOFF, A. (2002). Transient relaxation of rat mesenteric microvessels by ceramides. Br. J. Pharmacol., 135, 417-426.
36. DANTAS, A.P.V., IGARASHI, J. & MICHEL, T. (2003). Sphingosine 1-phosphate and control of vascular tone. Am. J. Physiol., 284, H2045-H2052.
37. DETTBARN, C.S., BETTO, R., SALVIATI, G., PALADE, P., JENKINS, G.M. & SABBADINI, R.A. (1994). Modulation of cardiac sarcoplasmic reticulum ryanodine receptor by sphingosine. J. Mol. Cell Cardiol., 26, 229-242.
38. ENDO, A., NAGASHIMA, K., KUROSE, H., MOCHIZUKI, S., MATSUDA, M. & MOCHIZUKI, N. (2002). Sphingosine 1-phosphate induces membrane ruffling and increases motility of human umbilical vein endothelial cells via vascular endothelial growth factor receptor and CrkII. J. Biol. Chem., 277, 23747-23754.
39. ENGLISH, D., BRINDLEY, D.N., SPIEGEL, S. & GARCIA, J.G. (2002). Lipid mediators of angiogenesis and the signalling pathways they initiate. Biochim. Biophys. Acta, 1582, 228-239.
40. ENGLISH, D., GARCIA, J.G. & BRINDLEY, D.N. (2001). Platelet-released phospholipids link haemostasis and angiogenesis. Cardiovasc. Res., 49, 588-599.
41. ENGLISH, D., WELCH, Z., KOVALA, A.T., HARVEY, K., VOLPERT, O.V., BRINDLEY, D.N. & GARCIA, J.G. (2000). Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis. FASEB J., 14, 2255-2265.
42. ERDREICH-EPSTEIN, A., TRAN, L.B., BOWMAN, N.N., WANG, H., CABOT, M.C., DURDEN, D.L., VLCKOVA, J., REYNOLDS, C.P., STINS, M.F., GROSHEN, S. & MILLARD, M. (2002). Ceramide signaling in fenretinide-induced endothelial cell apoptosis. J. Biol. Chem., 277, 49531-49537.
43. FORREST, M., SUN, S.-Y., HAJDU, R., BERGSTROM, J., CARD, D., DOHERTY, G., HALE, J., KEOHANE, C., MEYERS, C., MILLIGAN, J., MILLS, S., NOMURA, N., ROSEN, H., ROSENBACH, M., SHEI, G., SINGER, I.I., TIAN, M., WEST, S., WHITE, V., XIE, J., PROIA, R. & MANDALA, S. (2004). Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor sub-types. J. Pharmacol. Exp. Ther., 309, 758-768.
44. FRIEDRICHS, G.S., SWILLO, R.E., JOW, B., BRIDAL, T., NUMANN, R., WARNER, L.M., KILLAR, L.M. & SIDEK, K. (2002). Sphingosme modulates myocyte electrophysiology, induces negative inotropy, and decreases survival after myocardial ischaemia. J. Cardiovasc. Pharmacol., 39, 18-28.
45. FULTON, D., GRATTON, J.P., MCCABE, T.J., FONTANA, J., FUJIO, Y., WALSH, K., FRANKE, T.F., PAPAPETROPOULOS, A. & SESSA, W.C. (1999). Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature, 399, 597-601.
46. GONDA, K., OKAMOTO, H., TAKUWA, N., YATOMI, Y., OKAZAKI, H., SAKURAI, T., KIMURA, S., SILLARD, R., HARII, K. & TAKUWA, Y. (1999). The novel sphingosine 1-phosphate receptor AGR16 is coupled via pertussis toxin-sensitive and -insensitive G-proteins to multiple signalling pathways. Biochem. J., 337, 67-75.
47. GRALER, M.H., BERNHARDT, G. & LIPP, M. (1998). EDG6, a novel G-protein-coupled receptor related to receptors for bioactive lysophospholipids, is specifically expressed in lymphoid tissue. Genomics, 53, 164-169.
48. GUO, J., MACDONELL, K.L. & GILES, W.R. (1999). Effects of sphingosine 1-phosphate on pacemaker activity in rabbit sino-atrial cells. Pflügers Arch., 438, 642-648.
49. HANNUN, Y.A., LUBERTO, C. & ARGRAVES, K.M. (2001). Enzymes of sphingolipid metabolism: from modular to integrative signaling. Biochemistry, 40, 4893-4903.
50. HAYAKAWA, Y., TAKEDA, K., YAGITA, H., SMYTH, M.J., VAN KAER, L., OKUMURA, K. & SAIKI, I. (2002). IFN-gamma-mediated inhibition of tumor angiogenesis by natural killer T-cell ligand, alpha-galactosylceramide. Blood, 100, 1728-1733.
51. HEDEMANN, J., PETERS, S.L. & MICHEL, M.C. (2004). Comparison of vascular lysosphingolipid responses in rats and mice. Fundam. Clin. Pharmacol., 18 (Suppl. 1), 60.
52. HERNANDEZ, O.M., DISCHER, D.J., BISHOPRIC, N.H. & WEBSTER, K.A. (2000). Rapid activation of neutral sphingomyelinase by hypoxia-reoxygenation of cardiac myocytes. Biochem. Biophys. Res. Commun., 86, 198-204.
53. HIGUCHI, K., HARA, J., OKAMOTO, R., KAWASHIMA, M. & IMOKAWA, G. (2000). The skin of atopic dermatitis patients contains a novel enzyme, glucosylceramide sphingomyelin deacylase, which cleaves the N-acyl linkage of sphingomyelin and glucosylceramide. Biochem. J., 350, 747-756.
54. HIMMEL, H.M., MEYER ZU HERINGDORF, D., GRAF, E., DOBREV, D., KORTNER, A., SCHULER, S., JAKOBS, K.H. & RAVENS, U. (2000). Evidence for Edg-3 receptor-mediated activation of I(K.ACh) by sphingosine-1-phosphate in human atrial cardiomyocytes. Mol. Pharmacol., 58, 449-454.
55. HLA, T. & MACIAG, T. (1990a). An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors. J. Biol. Chem., 265, 9308-9313.
56. HLA, T. & MACIAG, T. (1990b). Isolation of immediate-early differentiation mRNAs by enzymatic amplification of subtracted cDNA from human endothelial cells. Biochem. Biophys. Res. Commun., 167, 637-643.
57. HOBSON, J.P., ROSENFELDT, H.M., BARAK, L.S., OLIVERA, A., POULTON, S., CARON, M.G., MILSTIEN, S. & SPIEGEL, S. (2001). Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility. Science, 291, 1800-1803.
58. HOFMANN, U., DOMEIER, E., FRANTZ, S., LASER, M., WECKLER, B., KUHLENCORDT, P., HEUER, S., KEWELOH, B., ERTL, G. & BONZ, A.W. (2003). Increased myocardial oxygen consumption by TNF-alpha is mediated by a sphingosine signaling pathway. Am. J. Physiol., 284, H2100-H2105.
59. IGARASHI, J., BERNIER, S.G. & MICHEL, T. (2001). Sphingosine 1-phosphate and activation of endothelial nitric-oxide synthase. Differential regulation of Akt and MAP kinase pathways by EDG and bradykinin receptors in vascular endothelial cells. J. Biol. Chem., 276, 12420-12426.
60. IGARASHI, J., ERWIN, P.A., DANTAS, A.P., CHEN, H. & MICHEL, T. (2003). VEGF induces S1P1 receptors in endothelial cells: implications for cross-talk between sphingolipid and growth factor receptors. Proc. Natl. Acad. Sci. U.S.A, 100, 10664-10669.
61. IM, D.S., HEISE, C.E., ANCELLIN, N., O'DOWD, B.F., SHEI, G.J., HEAVENS, R.P., RIGBY, M.R., HLA, T., MANDALA, S., MCALLISTER, G., GEORGE, S.R. & LYNCH, K.R. (2000). Characterization of a novel sphingosine 1-phosphate receptor, Edg-8. J. Biol. Chem., 275, 14281-14286.
62. ISHII, I., FRIEDMAN, B., YE, X., KAWAMURA, S., MCGIFFERT, C., CONTOS, J.J., KINGSBURY, M.A., ZHANG, G., BROWN, J.H. & CHUN, J. (2001). Selective loss of sphingosine 1-phosphate signaling with no obvious phenotypic abnormality in mice lacking its G protein-coupled receptor, LP(B3)/EDG-3. J. Biol. Chem., 276, 33697-33704.
63. JIN, Z.-Q., ZHOU, H.-Z., ZHU, P., HONBO, N., MOCHLY-ROSEN, D., MESSING, R.O., GOETZL, E.J., KARLINER, J.S. & GRAY, M.O. (2002). Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKCε knockout mouse hearts. Am. J. Physiol., 282, H1970-H1977.
64. JOHNS, D.G., JIN, J.-S. & WEBB, R.C. (1998). The role of the endothelium in cetamide-induced vasodilation. Eur. J. Pharmacol., 349, R9-R10.
65. JOHNS, D.G., OSBORN, H. & WEBB, R.C. (1997). Ceramide: a novel cell signaling mechanism for vasodilation. Biochem. Biophys. Res. Commun., 237, 95-97.
66. JOHNS, D.G., WEBB, R.C. & CHARPIE, J.R. (2001). Impaired ceramide signalling in spontaneously hypertensive rat vascular smooth muscle: a possible mechanism for augmented cell proliferation. J. Hypertens., 19, 63-70.
67. KARLINER, J.S., HONBO, N., SUMMERS, K., GRAY, M.O. & GOETZL, E.J. (2001). The lysophospholipids sphingosine-1-phosphate and lysophosphatidic acid enhance survival during hypoxia in neonatal rat cardiac myocytes. J. Mol. Cell. Cardiol., 33, 1713-1717.
68. KIMURA, T., SATO, K., MALCHINKHUU, E., TOMURA, H., TAMAMA, K., KUWABARA, A., MURAKAMI, M. & OKAJIMA, F. (2003). High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors. Arterioscler. Thromb. Vasc. Biol., 23, 1283-1288.
69. KIMURA, T., WATANABE, T., SATO, K., KON, J., TOMURA, H., TAMAMA, K., KUWABARA, A., KANDA, T., KOBAYASHI, I., OHTA, H., UI, M. & OKAJIMA, F. (2000). Sphingosine 1-phosphate stimulates proliferation and migration of human endothelial cells possibly through the lipid receptors, Edg-1 and Edg-3. Biochem. J., 348, 71-76.
70. KLUK, M.J. & HLA, T. (2001). Role of the sphingosine 1-phosphate receptor EDG-1 in vascular smooth muscle cell proliferation and migration. Circ. Res., 89, 496-502.
71. KOLESNICK, R. (2002). The therapeutic potential of modulating the ceramide/sphingomyelin pathway. J. Clin. Invest., 110, 3-8.
72. KROWN, K.A., PAGE, M.T., NGUYEN, C., ZECHNER, D., GUTIERREZ, V., COMSTOCK, K.L., GLEMBOTSKI, C.C., QUINTANA, P.J.E. & SABBADINI, R.A. (1996). Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J. Clin. Invest., 98, 2854-2865.
73. KWON, Y.G., MIN, J.K., KIM, K.M., LEE, D.J., BILLIAR, T.R. & KIM, Y.M. (2001). Sphingosine 1-phosphate protects human umbilical vein endothelial cells from serum-deprived apoptosis by nitric oxide production. J. Biol. Chem., 276, 10627-10633.
74. LANGLOIS, S., GINGRAS, D. & BELIVEAU, R. (2004). Membrane type 1-matrix metalloproteinase (MT1-MMP) cooperates with sphingosine 1-phosphate to induce endothelial cell migration and morphogenic differentiation. Blood, 103, 3020-3028.
75. LEE, M.J., THANGADA, S., CLAFFEY, K.P., ANCELLIN, N., LIU, C.H., KLUK, M., VOLPI, M., SHA'AFI, R.I. & HLA, T. (1999a). Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell. 99, 301-312.
76. LEE, M.J., VAN BROCKLYN, J.R., THANGADA, S., LIU, C.H., HAND, A.R., MENZELEEV, R., SPIEGEL, S. & HLA, T. (1998). Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science, 279, 1552-1555.
77. LEE, O.H., KIM, Y.M., LEE, Y.M., MOON, E.J., LEE, D.J., KIM, J.H., KIM, K.W. & KWON, Y.G. (1999b). Sphingosine 1-phosphate induces angiogenesis: its angiogenic action and signaling mechanism in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun., 264, 743-750.
78. LEE, P.C., SALYAPONGSE, A.N., BRAGDON, G.A., SHEARS II, L.L., WATKINS, S.C., EDINGTON, H.D. & BILLIAR, T.R. (1999c). Impaired wound healing and angiogenesis in eNOS-deficient mice. Am. J. Physiol., 277, H1600-H1608.
79. LEVEEN, P., PEKNY, M., GEBRE-MEDHIN, S., SWOLIN, B., LARSSON, E. & BETSHOLTZ, C. (1994). Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev., 8, 1875-1887.
80. LI, P.L., ZHANG, D.X., ZOU, A.P. & CAMPBELL, W.B. (1999). Effect of ceramide on KCa channel activity and vascular tone in coronary arteries. Hypertension, 33, 1441-1446.
81. LILIOM, K., SUN, G., BUNEMANN, M., VIRAG, T., NUSSER, N., BAKER, D.L., WANG, D.A., FABIAN, M.J., BRANDTS, B., BENDER, K., EICKEL, A., MALIK, K.U., MILLER, D.D., DESIDERIO, D.M., TIGYI, G. & POTT, L. (2001). Sphingosylphosphocholine is a naturally occurring lipid mediator in blood plasma: a possible role in regulating cardiac function via sphingolipid receptors. Biochem. J., 355, 189-197.
82. LINDAHL, P., JOHANSSON, B.R., LEVEEN, P. & BETSHOLTZ, C. (1997). Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science, 277, 242-245.
83. LIU, F., VERIN, A.D., WANG, P., DAY, R., WERSTO, R.P., CHREST, F.J., ENGLISH, D.K., & GARCIA, J.G. (2001). Differential regulation of sphingosine-1-phosphate- and VEGF-induced endothelial cell chemotaxis. Involvement of G(ialpha2)-linked Rho kinase activity. Am. J. Respir. Cell. Mol. Biol., 24, 711-719.
84. 2+ influx. Am. J. Physiol., 285, H735-H744.
85. LIU, Y., WADA, R., YAMASHITA, T., MI, Y., DENG, C.X., HOBSON, J.P., ROSENFELDT, H.M., NAVA, V.E., CHAE, S.S., LEE, M.J., LIU, C.H., HLA, T., SPIEGEL, S. & PROIA, R.L. (2000). Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J. Clin. Invest., 106, 951-961.
86. LOPEZ-MARURE, R., VENTURA, J.L., SANCHEZ, L., MONTANO, L.F. & ZENTELLA, A. (2000). Ceramide mimics tumour necrosis factor-alpha in the induction of cell cycle arrest in endothelial cells. Induction of the tumour suppressor p53 with decrease in retinoblastoma/protein levels. Eur. J. Biochem., 267, 4325-4333.
87. MACDONELL, K.L., SEVERSON, D.L. & GILES, W.R. (1998). Depression of excitability by sphingosine 1-phosphate in rat ventricular myocytes. Am. J. Physiol., 275, H2291-H2299.
88. MAZURAIS, D., ROBERT, P., GOUT, B., BERREBI-BERTRAND, I., LAVILLE, M.P. & CALMELS, T. (2002). Cell type-specific localization of human cardiac S1P receptors. J. Histochem. Cytochem., 50, 661-670.
89. 2+ channel conductance. Circ. Res., 75, 981-989.
90. MEYER ZU HERINGDORF, D., HIMMEL, H.M. & JAKOBS, K.H. (2002). Sphingosylphosphorylcholine - biological functions and mechanisms of action. Biochim. Biophys. Acta, 1582, 178-189.
91. MEYER ZU HERINGDORF, D., VAN KOPPEN, C.J. & JAKOBS, K.H. (1997). Molecular diversity of sphingolipid signalling. FEBS Lett., 410, 34-38.
92. MIURA, S., TANIGAWA, H., MATSUO, Y., FUJINO, M., KAWAMURA, A. & SAKU, K. (2003). Ras/Raf1-dependent signal in sphingosine-1-phosphate-induced tube formation in human coronary artery endothelial cells. Biochem. Biophys. Res. Commun., 306, 924-929.
93. 2+ elevation in endothelial cells in situ and causes endothelium-dependent relaxation through nitric oxide production in bovine coronary artery. FEBS Lett., 457, 375-380.
94. MORALES-RUIZ, M., LEE, M.J., ZOLLNER, S., GRATTON, J.P., SCOTLAND, R., SHIOJIMA, I., WALSH, K., HLA, T. & SESSA, W.C. (2001). Sphingosine 1-phosphate activates Akt, nitric oxide production, and chemotaxis through a Gi protein/phosphoinositide 3-kinase pathway in endothelial cells. J. Biol. Chem., 276, 19672-19677.
95. MUROHARA, T., ASAHARA, T., SILVER, M., BAUTERS, C., MASUDA, H., KALKA, C., KEARNEY, M., CHEN, D., SYMES, J.F., FISHMAN, M.C., HUANG, P.L. & ISNER, J.M. (1998). Nitric oxide synthase modulates angiogenesis in response to tissue ischaemia. J. Clin. Invest., 101, 2567-2578.
96. MUROHARA, T., KUGIYAMA, K., OHGUSHI, M., SUGIYAMA, S., OHTA, Y. & YASUE, H. (1996). Effects of sphingomyelinase and sphingosine on arterial vasomotor regulation. J. Lipid Res., 37, 1601-1608.
97. NAKAJIMA, N., CAVALLI, A.L., BIRAL, D., GLEMBOTSKI, C.C., MCDONOUGH, P.M., HO, P.D., BETTO, R., SANDONA, D., PALADE, P.T., DETTBARN, C.A., KLEPPER, R.E. & SABBADINI, R.A. (2000). Expression and characterization of Edg-1 receptors in rat cardiomyocytes: calcium deregulation in response to sphingosine 1-phosphate. Eur. J. Biochem., 267, 5679-5686.
98. 2+ sensitization of coronary artery contraction mediated by a sphingosylphosphorylcholine-Rho-kinase pathway. Circ. Res., 91, 953-960.
99. NIEDERNBERG, A., TUNARU, S., BLAUKAT, A., ARDATI, A. & KOSTENIS, E. (2003). Sphingosine 1-phosphate and dioleoylphosphatidic acid are low affinity agonists for the orphan receptor GPR63. Cell. Signal., 15, 435-446.
100. 2. Cardiovasc. Res., 58, 170-177.
101. OKAJIMA, F. (2002). Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an anti-atherogenic mediator? Biochim. Biophys. Acta, 1582, 132-137.
102. OLIVERA, A. & SPIEGEL, S. (1993). Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens. Nature, 365, 557-560.
103. ORAL, H., DORN II, G.W. & MANN, D.L. (1997). Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-α in the adult mammalian cardiac myocyte. J. Biol. Chem., 272, 4836-4842.
104. PAIK, J.H., CHAE, S., LEE, M.J., THANGADA, S. & HLA, T. (2001). Sphingosine 1-phosphate-induced endothelial cell migration requires the expression of EDG-1 and EDG-3 receptors and Rho-dependent activation of alpha vbeta3- and beta1-containing integrins. J. Biol. Chem., 276, 11830-11837.
105. PANETTI, T.S., NOWLEN, J. & MOSHER, D.F. (2000). Sphingosine-1- phosphate and lysophosphatidic acid stimulate endothelial cell migration. Arterioscler. Thromb. Vasc. Biol., 20, 1013-1019.
106. PAYNE, S.G., MILSTIEN, S. & SPIEGEL, S. (2002). Sphingosine-1- phosphate: dual messenger functions. FEBS Lett., 531, 54-57.
107. PYNE, S. & PYNE, N.J. (2000). Sphingosine 1-phosphate signalling in mammalian cells. Biochem. J., 349, 385-402.
108. RADIN, N.S. (2003). Killing tumours by ceramide-induced apoptosis: a critique of available drugs. Biochem. J., 371, 243-256.
109. RELLING, D.P., HINTZ, K.K. & REN, J. (2003). Acute exposure of ceramide enhances cardiac contractile function in isolated ventricular myocytes. Br. J. Pharmacol., 140, 1163-1168.
110. RIKITAKE, Y., HIRATA, K., KAWASHIMA, S., OZAKI, M., TAKAHASHI, T., OGAWA, W., INOUE, N. & YOKOYAMA, M. (2002). Involvement of endothelial nitric oxide in sphingosine-1-phosphate-induced angiogenesis. Arterioscler. Thromb. Vasc. Biol., 22, 108-114.
111. ROBERT, P., TSUI, P., LAVILLE, M.P., LIVI, G.P., SARAU, H.M., BRIL, A. & BERREBI-BERTRAND, I. (2001). EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytes. J. Mol. Cell. Cardiol., 33, 1589-1606.
112. RUVOLO, P.P. (2003). Intracellular signal transduction pathways activated by ceramide and its metabolites. Pharmacol. Res., 47, 383-392.
113. RYU, Y., TAKUWA, N., SUGIMOTO, N., SAKURADA, S., USUI, S., OKAMOTO, H., MATSUI, O. & TAKUWA, Y. (2002). Sphingosine-1-phosphate, a platelet-derived lysophospholipid mediator, negatively regulates cellular Rac activity and cell migration in vascular smooth muscle cells. Circ. Res., 90, 325-332.
114. 3 receptors mediate the potent constriction of cerebral arteries by sphingosine-1-phosphate. Eur. J. Pharmacol., 469, 125-134.
115. 3 respectively regulate lymphocyte recirculation and heart rate. J. Biol. Chem., 279, 13839-13848.
116. SEKIGUCHI, K., YOKOYAMA, T., KURABAYASHI, M., OKAJIMA, F. & NAGAI, R. (1999). Sphingosylphosphorylcholine induces a hypertrophic growth response through the mitogen-activated protein kinase signaling cascade in rat neonatal cardiac myocytes. Circ. Res., 85, 1000-1008.
117. 2+ sensitization in the bovine cerebral artery. Unimportant role for protein kinase C. Circ. Res., 91, 112-119.
118. SHU, X., WU, W., MOSTELLER, R.D. & BROEK, D. (2002). Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogen-activated protein kinases. Mol. Cell. Biol., 22, 7758-7768.
119. SORIANO, P. (1994). Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes Dev., 8, 1888-1896.
120. SPIEGEL, S. & MILSTIEN, S. (2000). Functions of a new family of sphingosine-1-phosphate receptors. Biochim. Biophys. Acta, 1484, 107-116.
121. SPIEGEL, S. & MILSTIEN, S. (2002). Sphingosine 1-phosphate, a key cell signaling molecule. J. Biol. Chem., 277, 25851-25854.
122. SPIEGEL, S. & MILSTIEN, S. (2003). Exogenous and intracellularly generated sphingosine 1-phosphate can regulate cellular processes by divergent pathways. Biochem. Soc. Trans., 31, 1216-1219.
123. SUGISHITA, K., KINUGAWA, K., SHIMIZU, T., HARADA, K., MATSUI, H., TAKAHASHI, T., SERIZAWA, T. & KOHMOTO, O. (1999). Cellular basis for the acute inhibitory effects of IL-6 and TNF-α on excitation-contraction coupling. J. Mol. Cell. Cardiol., 31, 1457-1467.
124. SUGIYAMA, A., AYE, N.N., YATOMI, Y., OZAKI, Y. & HASHIMOTO, K. (2000a). Effects of sphingosine 1-phosphate, a naturally occurring biologically active lysophospholipid, on the rat cardiovascular system. Jpn. J. Pharmacol., 82, 338-342.
125. SUGIYAMA, A., YATOMI, Y., OZAKI, Y. & HASHIMOTO, K. (2000b). Sphingosine 1-phosphate induces sinus tachycardia and coronary vasoconstriction in the canine heart. Cardiovasc. Res., 46, 119-125.
126. TAKUWA, Y. (2002). Subtype-specific differential regulation of Rho family G proteins and cell migration by the Edg family sphingosine-1-phosphate receptors. Biochim. Biophys. Acta, 1582, 112-120.
127. TAKUWA, Y., OKAMOTO, H., TAKUWA, N., GONDA, K., SUGIMOTO, N. & SAKURADA, S. (2001). Subtype-specific, differential activities of the EDG family receptors for sphingosine-1-phosphate, a novel lysophospholipid mediator. Mol. Cell. Endocrinol. 177, 3-11.
128. TAMAMA, K., KON, J., SATO, K., TOMURA, H., KUWABARA, A., KIMURA, T., KANDA, T., OHTA, H., UI, M., KOBAYASHI, I. & OKAJIMA, F. (2001). Extracellular mechanism through the Edg family of receptors might be responsible for sphingosine-1-phosphate-induced regulation of DNA synthesis and migration of rat aortic smooth-muscle cells. Biochem. J., 353, 139-146.
129. TANIMOTO, T., JIN, Z.G. & BERK, B.C. (2002). Transactivation of vascular endothelial growth factor (VEGF) receptor Flk-1/KDR is involved in sphingosine 1-phosphate-stimulated phosphorylation of Akt and endothelial nitric-oxide synthase (eNOS). J. Biol. Chem., 277, 42997-43001.
130. THIELMANN, M., DÖRGE, H., MARTIN, C., BELOSJOROW, S., SCHWANKE, U., VAN DE SAND, A., KONIETZKA, I., BÜCHERT, A., KRÜGER, A., SCHULZ, R. & HEUSCH, G. (2002). Myocardial dysfunction with coronary microembolization. Signal transduction through a sequence of nitric oxide, tumor necrosis factor-α, and sphingosine. Circ. Res., 90, 807-813.
131. 2+-sensitization of vascular smooth muscle contraction: possible involvement of rho-kinase. FEBS Lett., 482, 85-90.
132. TOSAKA, M., OKAJIMA, F., HASHIBA, Y., SAITO, N., NAGANO, T., WATANABE, T., KIMURA, T. & SASAKI, T. (2001). Sphingosine 1-phosphate contracts canine basilar arteries in vitro and in vivo: possible role in pathogenesis of cerebral vasospasm. Stroke, 32, 2913-2919.
133. UEHARA, A., YASUKOCHI, M., IMANAGA, I. & BERLIN, J.R. (1999). Effect of sphingosylphosphorylcholine on the single channel gating properties of the cardiac ryanodine receptor. FEBS Lett., 460, 467-471.
134. UHLENBROCK, K., GASSENHUBER, H. & KOSTENIS, E. (2002). Sphingosine 1-phosphate is a ligand of the human gpr3, gpr6 and gpr12 family of constitutively active G protein-coupled receptors. Cell. Signal., 14, 941-953.
135. UHLENBROCK, K., HUBER, J., ARDATI, A., BUSCH, A.E. & KOSTENIS, E. (2003). Fluid shear stress differentially regulates gpr3, gpr6, and gpr12 expression in human umbilical vein endothelial cells. Cell. Physiol. Biochem., 13, 75-84.
136. i protein-coupled plasma membrane receptor by sphingosine-1-phosphate. J. Biol. Chem., 271, 2082-2087.
137. WANG, F., VAN BROCKLYN, J.R., HOBSON, J.P., MOVAFAGH, S., ZUKOWSKA-GROJEC, Z., MILSTIEN, S. & SPIEGEL, S. (1999). Sphingosine 1-phosphate stimulates cell migration through a G(i)-coupled cell surface receptor. Potential involvement in angiogenesis. J. Biol. Chem., 274, 35343-35350.
138. WEBSTER, R.J., SABBADINI, R.A., DETTBARN, C.A. & PAOLINI, P.J.
139. WECKING, C., MICHEL, M.C. & BISCHOFF, A. (2001). Effects of indomethacin on sphingolipid-induced diuresis and natriuresis. Naunyn-Schmiedeberg's Arch. Pharmacol., 363 (Suppl). R113.
140. XU, Y., ZHU, K., HONG, G., WU, W., BAUDHUIN, L.M., XIAO, Y. & DAMRON, D.S. (2000). Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1. Nat. Cell Biol., 2, 261-267.
141. YASUI, K. & PALADE, P. (1996). Sphingolipid actions on sodium and calcium currents of rat ventricular myocytes. Am. J. Physiol., 270, C645-C649.
142. 2+ and voltage dependence of cardiac ryanodine receptor channel block by sphingosylphosphorylcholine. Pflügers Arch., 445, 665-673.
143. YATOMI, Y., IGARASHI, Y., YANG, L., HISANO, N., QI, R., ASAZUMA, N., SATOH, K., OZAKI, Y. & KUME, S. (1997). Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J. Biochem. (Tokyo), 121, 969-973.
144. ZHANG, D.X., ZOU, A.-P. & LI, P.-L. (2001). Ceramide reduces endothelium-dependent vasodilation by increasing superoxide production in small bovine coronary arteries. Circ. Res., 88, 824-831.
145. ZHANG, G., CONTOS, J.J., WEINER, J.A., FUKUSHIMA, N. & CHUN, J. (1999). Comparative analysis of three murine G-protein coupled receptors activated by sphingosine-1-phosphate. Gene, 227, 89-99.
146. i in rat aortic smooth muscle. Lipids, 34, 689-695.